The Effects of Endurance Training on Lipedema
Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Aug 3, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of high-intensity interval training (HIIT) on women with a condition called lipedema, which causes excess fat to build up in the arms and legs, often leading to pain and limited movement. The researchers want to find out if this type of exercise can improve pain, quality of life, body composition (how much fat and muscle you have), fitness levels, and certain markers in the blood that indicate inflammation.
To participate in the trial, women between the ages of 18 and 75 who can attend supervised exercise sessions in Trondheim are eligible. However, those with eating disorders or certain physical limitations that affect their ability to exercise will not be included. Participants can expect to engage in a structured exercise program while helping to contribute to our understanding of how exercise might benefit those with lipedema. This could lead to better treatment options in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - can meet for supervised exercise training in Trondheim.
- Exclusion Criteria:
- • eating disorders and/or orthopedic limitations for exercise training
About Norwegian University Of Science And Technology
The Norwegian University of Science and Technology (NTNU) is a leading research institution dedicated to advancing knowledge and innovation in various scientific fields. Renowned for its commitment to interdisciplinary collaboration, NTNU plays a pivotal role in addressing global health challenges through rigorous clinical trials and research initiatives. The university's emphasis on cutting-edge technology and its strong partnerships with healthcare sectors position it as a key player in translational research, ensuring that findings contribute effectively to improving public health and patient care. With a focus on ethical standards and scientific integrity, NTNU is dedicated to fostering advancements that enhance the quality of life and health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, , Norway
Patients applied
Trial Officials
Øivind Rognmo, PhD
Study Director
Norwegian University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials